PharmaCyte Biotech Inc (PMCB)

[1234jklm]

The CEO is 75

They're going to get the cycaps fda approved with pancreatic cancer and then sell out or partner with big pharma on diabetes and other cures.

It will be bought by a big pharma to challenge sigilon's diabetes treatment because it will work better as it can be frozen and transported more easily and because no one wants to let a competitor own the only cure for diabetes by encapsulated cells.

Crabtree and kw are not going to be doing this much longer imho.

As they said in a recent pr, the pancreatic cancer trial is a trial of the technology in humans. It's not just about pc.

Once the technology is FDA approved, even to go to phase 3,this will be snapped up. Hopefully there'll be a bidding war as the sigilon treatment starts to work in early phase 1.

Yuen Crabtree and kw are all in their seventies. They're not looking for a decade more of work.